Mounjaro®
Starting from £179.99/mo
Start journey Learn moreLower back pain is listed in the Mounjaro patient information leaflet as an uncommon side effect, meaning it has been reported by fewer than one in a hundred people in clinical trials. Whether mounjaro is directly causing the discomfort, or whether something else is at play, depends on factors your prescriber needs to weigh. These are prescription-only medicines and every decision about continuing, pausing or adjusting treatment should involve a clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
If you're reading this, you're probably a few weeks into treatment and noticing something you didn't expect. That's a reasonable thing to look into, and the honest answer is: yes, mounjaro and lower back pain have an established, if uncommon, link. The Mounjaro summary of product characteristics lists back pain among adverse reactions observed in trials, classified as uncommon, appearing in roughly 0.1–1% of participants. That doesn't mean the medicine is necessarily the cause in your case, but it does mean you're not imagining a connection that doesn't exist.
Tirzepatide works by activating both GIP and GLP-1 gut-hormone receptors, slowing digestion and reducing appetite. What it does not do is act directly on spinal structures or musculature. So when lower back pain does arise on Mounjaro, clinicians tend to think through several indirect mechanisms rather than one obvious culprit, and our Mounjaro back pain page walks through each of those in detail. Understanding those mechanisms is the most useful thing this page can offer you.
You can find a broader overview of how tirzepatide is used in the UK on the tirzepatide information page, including how the treatment schedule is structured from the starting dose upwards.
The first is dehydration. Nausea, vomiting and diarrhoea are among the most common early side effects of tirzepatide, particularly after a dose increase. When fluid loss is sustained, muscle tissue becomes less well-supported and more prone to cramping or aching. The lower back is a common site for this kind of muscular discomfort, even in people who have never had back problems before. Staying well hydrated, especially during the first few weeks at each dose level, matters more than most people realise.
The second is postural change. Weight loss shifts the mechanical load on your skeleton. Joints and muscles that have adapted over years to a certain distribution of weight suddenly need to recalibrate. This can produce new aches in the lower back, hips and knees, sometimes transiently and sometimes requiring some active attention to posture and core strength. It is a sign the body is adjusting, not necessarily that anything is wrong.
The third is coincidence. Lower back pain is extraordinarily common in UK adults independent of any medicine. If you happen to experience it while on Mounjaro, the temporal link can feel causal when it isn't, and our tirzepatide back pain page covers how to think through that distinction and what to raise with your prescriber. Your prescriber can help you distinguish between a likely treatment-related effect and something that needs investigation in its own right.
The NHS guidance on tirzepatide covers the full side-effect profile, including musculoskeletal symptoms, and is worth reading alongside your patient information leaflet: NHS: tirzepatide.
Most lower back pain during mounjaro treatment is mild, eases within days, and does not require stopping the medicine. But some presentations need prompt assessment. Contact a doctor or call 111 if your lower back pain is severe, is localised to one side (flank pain), or arrives alongside fever, changes to urination, blood in urine, or nausea that feels different from your usual treatment-related GI symptoms. These can point towards a kidney or urinary-tract issue that needs investigation independently of your weight-loss treatment.
Pancreatitis, while uncommon, is a known risk with GLP-1 class medicines. The MHRA highlighted this in a Drug Safety Update and the symptom to watch for is severe abdominal pain that radiates through to the back, often accompanied by vomiting. This is distinct from the dull muscular ache most people mean when they say lower back pain, but it is worth being aware of. If that pattern fits your symptoms, seek urgent care rather than waiting for your next scheduled appointment.
For more detail on back pain specifically as a reported Mounjaro experience, including what the evidence says and what questions to bring to your next review, the can Mounjaro cause back pain page goes into further depth. There is also a dedicated page covering upper back pain and Mounjaro for those whose discomfort is higher in the spine.
The decision about whether to continue Mounjaro, pause at your current dose, or adjust your approach is a clinical one. It depends on the nature of your back pain, how long it has lasted, your full medical picture, and how your treatment is progressing overall. No page, including this one, can make that call for you.
What is worth knowing is that mounjaro lower back pain, where it is genuinely treatment-related, often settles once the body adjusts to a dose. Many prescribers would take a watch-and-wait approach for mild, musculoskeletal-type discomfort, particularly around titration steps, while keeping a closer eye on anything that changes character or intensifies. Hydration, gentle movement and temporarily avoiding exercises that load the lower back (heavy lifting, for example) are practical steps while you get clarity.
If you're thinking about the broader cost of private treatment alongside these concerns, the Mounjaro prices page sets out the market context plainly, including what a legitimate prescription service includes. And if you have a broader question about whether this treatment is right for your situation, speaking to a prescriber is always the right starting point. At nume, a GPhC-registered Independent Prescriber reads every consultation the same day. Speak to our prescribers to discuss your situation in full.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.